SPRTN

protein-coding

SprT-like N-terminal domain

Gene summary

The protein encoded by this gene may play a role in DNA repair during replication of damaged DNA. This protein recruits valosin containing protein (p97) to stalled DNA replication forks where it may prevent excessive translesional DNA synthesis and limit the number of DNA-damage induced mutations. It may also be involved in replication-related G2/M-checkpoint regulation. Deficiency of a similar protein in mouse causes chromosomal instability and progeroid phenotypes. Mutations in this gene have been associated with Ruijs-Aalfs syndrome (RJALS). Alternatively spliced transcript variants have been identified. [provided by RefSeq, Mar 2015]

Previous symbols:
  • C1orf124

MANE transcript

NM_032018.7

Inheritance

AR

ClinVar variants

P:4U:49B:15

Top phenotype

progeroid features-hepatocellular carcinoma predisposition syndrome

gnomAD constraint

pLI —, LoF o/e 0.06

Max pathogenic AF

—

Genomic locus

chr1:231,337,104-231,355,023

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~17.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

progeroid features-hepatocellular carcinoma predisposition syndromeLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0014527

Submitter: G2P

progeroid features-hepatocellular carcinoma predisposition syndromeLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0014527

Submitter: Labcorp Genetics (formerly Invitae)

progeroid features-hepatocellular carcinoma predisposition syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0014527

Submitter: Orphanet

progeroid features-hepatocellular carcinoma predisposition syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0014527

Submitter: PanelApp Australia

progeroid features-hepatocellular carcinoma predisposition syndromeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0014527

Submitter: Ambry Genetics

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SPRTN variants in ClinVar

7 Conditions Cataloged
Inborn genetic diseasesTotal: 49
not providedTotal: 15
SPRTN-related disorderTotal: 3
Progeroid features-hepatocellular carcinoma predisposition syndromeTotal: 3
Abnormal sperm morphologyTotal: 1
Reduced sperm motilityTotal: 1
OligospermiaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_032018.7. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
8
clinvar
2
clinvar
10
missense
1
clinvar
49
clinvar
3
clinvar
2
clinvar
55
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total314911468

Highest pathogenic variant AF is 0.000014372104

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 16 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_032018.7RefSeqNP_114407.35MANE Select
ENST00000295050.12EnsemblENSP00000295050.75MANE Select
NM_001010984.4RefSeqNP_001010984.14Standard
NM_001261462.3RefSeqNP_001248391.13Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
sprtnDanio rerio

Structure: whole organism

Quality: decreased life span

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • DNA Repair
  • Translesion Synthesis by POLH
  • Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template
  • DNA Damage Bypass

Biological Process

  • cellular response to DNA damage stimulus
  • response to UV
  • translesion synthesis
  • positive regulation of protein ubiquitination
  • error-free translesion synthesis

Molecular Function

  • DNA binding
  • protein binding
  • ubiquitin binding
  • metal ion binding
  • K63-linked polyubiquitin modification-dependent protein binding

Cellular Component

  • nucleus
  • nucleoplasm
  • chromosome
  • nuclear speck

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000295050
Coding exons
5
Length
17920
Individuals with no LoFs
125735
Homozygous LoFs
0
Heterozygous LoFs
13
Defined
125748
p
0.0000517
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.7392322660.8730.00001313243
Missense (PolyPhen)5086.5940.57741963
Synonymous-0.45510599.21.060.00000511914
Loss of Function3.43115.60.06419.34e-7154

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American0.0000870.000087rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000460.000046rare
European (Non-Finnish)0.0000620.000062rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Regulator of UV-induced DNA damage response: acts as a 'reader' of ubiquitinated PCNA that enhances RAD18-mediated PCNA ubiquitination and translesion DNA synthesis (TLS). Recruited to sites of UV damage and interacts with ubiquitinated PCNA and RAD18, the E3 ubiquitin ligase that monoubiquitinates PCNA. Facilitates chromatin association of RAD18 and is required for efficient PCNA monoubiquitination, promoting a feed-forward loop to enhance PCNA ubiquitination and translesion DNA synthesis. Acts as a regulator of TLS by recruiting VCP/p97 to sites of DNA damage, possibly leading to extraction of DNA polymerase eta (POLH) by VCP/p97 to prevent excessive translesion DNA synthesis and limit the incidence of mutations induced by DNA damage. {ECO:0000269|PubMed:22681887, ECO:0000269|PubMed:22894931, ECO:0000269|PubMed:22902628, ECO:0000269|PubMed:22987070, ECO:0000269|PubMed:23042605, ECO:0000269|PubMed:23042607}.;
Disease
DISEASE: Ruijs-Aalfs syndrome (RJALS) [MIM:616200]: A syndrome characterized by genomic instability, progeroid features, and susceptibility toward early onset hepatocellular carcinoma. {ECO:0000269|PubMed:25261934}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0968

Intolerance Scores

RVIS EVS
-0.58
RVIS percentile EVS
18.72

Essentials

Essential (CRISPR)
E
Essential (CRISPR2)
E
Essential (gene trap)
E

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.